trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Urate lowering therapy is effective at reducing serum urate levels in patients.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Urate lowering therapy is effective at reducing serum urate levels in patients?

Yes. Clinical trials and meta-analyses consistently demonstrate that urate-lowering therapy successfully reduces serum uric acid levels and achieves targeted biochemical control in patients.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently supports the pharmacological efficacy of urate-lowering therapies (ULT) such as xanthine oxidase inhibitors and URAT1 inhibitors in reducing serum urate levels and meeting treatment targets. While some papers debate the broader cardiovascular or metabolic benefits in asymptomatic populations, the primary biochemical efficacy of lowering serum urate is well-established across multiple clinical and review studies.

Evidence for · 5
Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio-renal-metabolic risk modulation.
2026
Reviews pharmacological evidence confirming that urate-lowering therapies effectively lower serum uric acid levels as a therapeutic target.
Get citation
C, B., F, F., & AFG, C. (2026). Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio-renal-metabolic risk modulation.. doi.org. https://doi.org/10.1093/ehjcvp/pvag042

See more details
More for · 4
Hyperuricemia, Urate-Lowering Therapy, and Renal Outcomes: A Systematic Review and Meta-Analysis
2018
Demonstrates through meta-analysis that urate-lowering therapies significantly improve renal outcomes and biomarkers when used for over a year.
Get citation
Sharma, G., Dubey, A., Nolkha, N., & Singh, J. (2018). Hyperuricemia, Urate-Lowering Therapy, and Renal Outcomes: A Systematic Review and Meta-Analysis. doi.org. https://doi.org/10.2139/ssrn.3279190

URAT1 inhibition in hyperuricemia and gout: from transporter biology to clinical precision therapy.
2026
Highlights that selective urate-lowering agents effectively block tubular reabsorption to reduce serum urate in patients.
Get citation
G, L., Y, W., & Z, Z. (2026). URAT1 inhibition in hyperuricemia and gout: from transporter biology to clinical precision therapy.. doi.org. https://doi.org/10.3389/fimmu.2026.1915148

Efficacy and Safety of Ultra-Low Starting Dose Febuxostat Titration in Male Patients With Primary Gout.
2026
Shows that individualized dosing and titration of febuxostat successfully achieve long-term serum uric acid target attainment.
Get citation
S, H., L, Y., G, L., S, R., G, X., & L, P. (2026). Efficacy and Safety of Ultra-Low Starting Dose Febuxostat Titration in Male Patients With Primary Gout.. doi.org. https://doi.org/10.1111/1756-185x.70800

The efficacy and safety of benzbromarone and febuxostat in combined-type hyperuricemia: a single-center study.
2026
Confirms that urate-lowering agents like benzbromarone and febuxostat successfully reduce serum urate levels to target thresholds.
Get citation
B, Z., R, Y., L, Z., G, F., L, Y., L, J., & Y, S. (2026). The efficacy and safety of benzbromarone and febuxostat in combined-type hyperuricemia: a single-center study.. doi.org. https://doi.org/10.1007/s10067-026-08314-5

What does the evidence say?

The retrieved literature consistently supports the pharmacological efficacy of urate-lowering therapies (ULT) such as xanthine oxidase inhibitors and URAT1 inhibitors in reducing serum urate levels and meeting treatment targets. While some papers debate the broader cardiovascular or metabolic benefits in asymptomatic populations, the primary biochemical efficacy of lowering serum urate is well-established across multiple clinical and review studies.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work